Table 2.
Association of clinical predictors with prevalent cervical precancerous lesions in 282 women initiating HAART in Cameroon
| Characteristic | N | ANY CERVICAL PRECANCEROUS LESION | ASC-H/HSIL | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Prev (%) | OR* | 95% CI | aOR** | 95% CI | Prev (%) | OR* | 95% CI | aOR** | 95% CI | ||
| Marital status | |||||||||||
| Single, never married | 59 | 42.4 | 1. | - | 1. | - | 18.6 | 1. | - | 1. | - |
| Married/in partnership | 98 | 43.9 | 1.06 | 0.55, 2.04 | 0.99 | 0.47, 2.11 | 17.4 | 0.92 | 0.40, 2.12 | 0.95 | 0.37, 2.49 |
| Separated/divorced/widowed | 119 | 43.7 | 1.05 | 0.56, 1.98 | 0.95 | 0.45, 2.01 | 17.7 | 0.94 | 0.42, 2.10 | 0.89 | 0.34, 2.34 |
| Education | |||||||||||
| None/primary | 144 | 43.1 | 1. | - | 1. | - | 17.4 | 1. | - | 1. | - |
| Secondary/tertiary | 132 | 43.9 | 1.04 | 0.64, 1.67 | 1.24 | 0.71, 2.16 | 18.2 | 1.06 | 0.57, 1.96 | 1.05 | 0.51, 2.18 |
| Residence | |||||||||||
| Urban | 204 | 39.7 | 1. | - | 1. | - | 16.7 | 1. | - | 1. | - |
| Rural | 72 | 54.2 | 1.79 | 1.04, 3.09 | 1.68 | 0.88, 3.18 | 20.8 | 1.32 | 0.67, 2.59 | 1.20 | 0.52, 2.74 |
| Age (years) | |||||||||||
| 25 and less or 60+ | 32 | 37.5 | 1. | - | 1. | - | 21.9 | 1. | - | 1. | - |
| 26–59 | 243 | 44.0 | 1.31 | 0.61, 2.80 | 1.57 | 0.65, 3.81 | 16.9 | 0.72 | 0.29, 1.79 | 1.07 | 0.35, 3.24 |
| Previous use of pills | |||||||||||
| No | 210 | 43.8 | 1. | - | 1. | - | 18.6 | 1. | - | 1. | - |
| Yes | 66 | 42.4 | 0.95 | 0.54, 1.65 | 0.95 | 0.50, 1.83 | 15.2 | 0.78 | 0.37, 1.67 | 0.83 | 0.34, 2.01 |
| Exposure to tobacco smoke | |||||||||||
| No | 137 | 46.0 | 1. | - | 1. | - | 19.7 | 1. | - | 1. | - |
| Yes | 139 | 41.0 | 0.82 | 0.51, 1.32 | 0.86 | 0.51, 1.46 | 15.8 | 0.77 | 0.41, 1.42 | 0.66 | 0.33, 1.34 |
| Age at first sex (years) | |||||||||||
| 16 or less | 126 | 45.2 | 1.18 | 0.71, 1.98 | 1.17 | 0.69, 2.01 | 19.1 | 1.27 | 0.64, 2.53 | 1.31 | 0.65, 2.63 |
| More than 16 | 141 | 41.1 | 1. | - | 1. | - | 15.6 | 1. | - | 1. | - |
| Parity | |||||||||||
| 2 or less | 152 | 42.1 | 1. | - | 1. | - | 17.8 | 1. | - | 1. | - |
| More than 2 | 124 | 45.2 | 1.13 | 0.70, 1.83 | 1.04 | 0.59, 1.83 | 17.7 | 1.00 | 0.54, 1.86 | 0.95 | 0.45, 2.00 |
| Time since HIV diagnosis | |||||||||||
| 1 year or less | 165 | 44.2 | 1. | - | 1. | - | 18.2 | 1. | - | 1. | - |
| More than 1 year | 111 | 42.3 | 0.93 | 0.57, 1.50 | 0.83 | 0.49, 1.42 | 17.1 | 0.93 | 0.49, 1.75 | 0.97 | 0.48, 1.97 |
| WHO HIV stage | |||||||||||
| I/II | 51 | 54.9 | 1. | - | 1. | - | 19.6 | 1. | - | 1. | - |
| III/IV | 225 | 40.9 | 0.57 | 0.31, 1.05 | 0.63 | 0.32, 1.23 | 17.3 | 0.86 | 0.40, 1.86 | 0.95 | 0.39, 2.27 |
| CD4 count (/μL) | |||||||||||
| Less than 200 | 155 | 42.6 | 1.04 | 0.61, 1.78 | 1.10 | 0.64, 1.88 | 19.4 | 1.46 | 0.71, 3.09 | 1.49 | 0.72, 3.07 |
| 200 or more | 106 | 41.5 | 1. | - | 1. | - | 14.2 | 1. | - | 1. | - |
*
OR: unadjusted odds ratio;
**
aOR: adjusted for all other covariates in table; OR: Odds ratio; Prev: Prevalence; CI: confidence interval.